Iranian Journal of Pharmaceutical Sciences

Vol. 1 No. 2 (2005)

Heparin Resistance During and Post-Intravenous Nitroglycerin Infusion Heparin and nitroglycerin interaction

Iranian Journal of Pharmaceutical Sciences, Vol. 1 No. 2 (2005), 1 April 2005 , Page 77-80
https://doi.org/10.22037/ijps.v1.39446

Abstract

Nitroglycerin has been reported to reduce activated partial thromboplastin time (aPTT) values in patients treated with concurrent heparin and nitroglycerin. However, studies have yielded conflicting results. To determine whether intravenous nitroglycerin alters the anticoagulant effect of heparin, we prospectively evaluated twenty patients admitted for coronary angioplasty by measuring their aPTT both before initiation and after addition of nitroglycerin to heparin therapy. The results showed that the mean of aPTT at the baseline when patients were on heparin alone was not significantly different from aPTT measured upon addition of nitroglycerin, and 30 min following the cessation of nitroglycerin infusion, when patients were still on the same dose of heparin. Therefore, no direct effect of nitroglycerin on the anticoagulant effect of heparin was observed in this study.

Keywords:
  • Heparin
  • Nitroglycerin
  • Resistance

How to Cite

Mojtahedzadeh, M. ., Khalili, H. ., Mohagheghi, A. ., & Dashti-Khavidaki, S. . (2005). Heparin Resistance During and Post-Intravenous Nitroglycerin Infusion: Heparin and nitroglycerin interaction. Iranian Journal of Pharmaceutical Sciences, 1(2), 77–80. https://doi.org/10.22037/ijps.v1.39446

References

[1] Chandra KK, Malhotra S, Gupta M, Grover A, Sharma N, Pandhi P. Changing trends in the hospital management of unstable angina: a drug utilization analysis. Int J Clin Pharmacol Ther 2004; 42: 575-80.
[2] Schulman SP. Antiplatelet therapy in non-STsegment elevation acute coronary syndromes. JAMA 2004; 292: 1875-82.
[3] Aronow WS. Drug treatment of elderly patients with acute myocardial infarction: practical recommendations. Drugs Aging 2001; 18: 807-18.
[4] Col J, Col-Debeys C, Lavenne-Pardonge F, Meert P, Hericks L, Broze MC, Moriau M. Propylene glycol-induced heparin resistance during nitroglycerin infusion. Am Heart J 1985; 110: 171-3.
[5] Barnes AD, Horn JR, Wittkowsky AK. Lack of in vitro interaction between heparin and nitroglycerin. Am J Clin Pathol 1996; 105: 298- 300.
[6] Koh KK, Park GS, Song JH, Moon TH, In HH, Kim JJ, Lee HJ, Cho SK, Kim SS. Interaction of intravenous heparin and organic nitrates in acute ischemic syndromes. Am J Cardiol 1995; 76: 706-9.
[7] Pye M, Oldroyd KG, Conkie JA, Hutton I, Cobbe SM. A clinical and in vitro study on the possible interaction of intravenous nitrates with heparin anticoagulation. Clin Cardiol 1994; 17: 658-61.
[8] Nottestad SY, Mascette AM. Nitroglycerininduced heparin resistance: absence of interaction at clinically relevant doses. Mil Med 1994; 159: 569-71.
[9] Brack MJ, More RS, Hubner PJ, Gershlick AH. The effect of different nitrate preparations on plasma heparin concentrations and the activated partial thromboplastin time. Postgrad Med J 1994; 70: 100-3.
[10] Berk SI, Grunwald A, Pal S, Bodenheimer MM. Effect of intravenous nitroglycerin on heparin dosage requirements in coronary artery disease. Am J Cardiol 1993; 72: 393-6.
[11] Brack MJ, More RS, Spring E, Gershlick AH. Therapeutic levels of nitroglycerin do not affect the uptake and release of heparin by endothelial cells in vitro. Thromb Res 1993; 70: 329-35.
[12] Bushe C, Wales E. Apossible interaction between heparin and intravenous nitroglycerin. Am J Cardiol 1991: 68: 290.
[13] Amin F, Horrow J. Nitroglycerin antagonism of heparin. Anesthesilogy 1990; 73: 193-4.
  • Abstract Viewed: 304 times
  • IJPS_Volume 1_Issue 2_Pages 77-80 Downloaded: 220 times

Download Statastics

Developed By

Open Journal Systems

Information